Dyadic
About Dyadic
Investor Information
News and Media
Careers
Technology Platform
Genomic Products & Services
Enzymes
Manufacturing Services






Investor Presentation
January 2012
The Power of Proteins
Read more
Article in Renewable Energy Magazine
August 2011
Green Sugars™, the Next Oil
Read more
Article in Biofuels Journal
June 2011
Bioenzyme For Biofuels
Read more
The World Conference on Industrial Biotechnology and Bioprocessing Conference Presentation
May 11, 2011
Efficient Saccharification of Lignocellulosic Feedstocks Using the C1-Technology Platform
Read more
Advance Biofuels Leadership Conference Presentation
April 20, 2011
Continuing Enzymatic Enhancements
Read more
Biofuels International
March 2011
Easy to Digest Enzymes
Read more
Presentation at World Biofuels Markets 2011
March 24, 2011
The C1 technology platform - Facilitating the economic production of lignocellulose based biofuels and chemicals
Read more
Presentation at World Biofuels Markets 2011
March 23, 2011
Cost efficient production of fuels and chemicals based on lignocellulose
Read more
Presentation at Renewable Fuels Association 16th Annual National Ethanol Conference
February 20-22, 2011
Building Bridges To A More Sustainable Future
Read more
Dyadic International, Inc. Presents at Rodman & Renshaw
September 2010
Read more
EnGen Bio Presents at Rodman & Renshaw
September 2010
Read more
Treasure Coast Business Journal
August 2010
Mark Emalfarb of Dyadic International - R&D Powerhouses Never Gives Up
Read more
The Palm Beach Post Money
December 2009
Best, worst performers of 2009 for Palm Beach County and Treasure Coast
Read more
TCPalm.com
November 2009
Future is sweet for Jupiter CEO
Read more
RENEWABLE ENERGY MAGAZINE
October 2009
INTERVIEW: Mark Emalfarb, CEO of biofuel innovator, Dyadic International
Read more
Florida Trend
September 2009
A Matter of Chemistry
Read more
Interviews of Mark Emalfarb at the Sixth Annual World Congress on Industrial Biotechnology & Bioprocessing
August 2009
View Video
South Florida Business Journal
May 2009
Dyadic CEO Makes A Comeback, Company sues prominent legal and accounting firms
Read more
Ethanol Producer Magazine
January 2007
Enabling the Biorefinery Concept
Read more
Ethanol Producer Magazine
January 2007
The Discoverer's Game
Read more
BusinessWeek
December 2006
Put A Termite In Your Tank
Read more
Nature [registration required]
Vol. 444, 7 December 2006
A Field in Ferment
Read more
Entrepreneur
December 2006
Dyadic Snapshot -- Good Genes
Read more
Chicago Tribune
October 13, 2006
Beyond corn: Ethanol's next generation:
Scientists seek cheap, plentiful energy alternatives

Read more
Ethanol Today
October 2006
Cellulosic Ethanol: Harvesting the Potential
Read more
Distillers Grains Quarterly
Fall 2006
Coproduct Breakdown
Read more
Society for Industrial Microbiology Annual Industrial Microbiology and Biotechnology Meeting
August 1, 2006
Presentation by Richard Burlingame, Ph.D.
Read more

U.S. Department of Agriculture
2006
Ethanol Production from Alkaline Peroxide Pretreated Enzymatically Saccharified Wheat Straw
Read more

BioPharm International
May 1, 2006
Maximizing Protein Expression in Filamentous Fungi
Read more

ETHANOL: DOE lays out research plan for cellulosic fuel production
Read Press Release
Breaking the Biological Barriers to Cellulosic Ethanol: A Joint Research Agenda (Full Report)
For information regarding News and Media please contact investors@dyadic.com


 
Dyadic International Stockholder Class Action Lawsuit Resolved

Jupiter, Fla.

April 19, 2010

Dyadic International, Inc. (Pink Sheets:DYAI) (“Dyadic”) announced today an agreement to resolve the consolidated stockholder class action lawsuit against Dyadic and certain of its current and former officers and directors which was initially filed in October 2007.

The litigation, Miller v. Dyadic International, Inc. et al, pending in the United States District Court for the Southern District of Florida, asserted class action claims under federal securities laws based on allegations of misstatements and omissions by Dyadic and certain of its current and former officers and directors arising out of alleged improprieties at Dyadic’s Asian subsidiaries. The final settlement of this lawsuit is conditioned upon the approval of a Stipulation of Settlement which has been submitted by the parties to the Court. The Stipulation of Settlement provides for payment to the alleged class of $4.8 million in cash to be funded by Dyadic and its insurance carriers. If approved by the Court, the settlement will lead to dismissal of the lawsuit with prejudice. As reported in Dyadic’s consolidated financial statements for the year ended December 31, 2009, Dyadic established a reserve in connection with the class action lawsuit which is adequate to cover the costs associated with resolving this matter.

Mark Emalfarb, President and Chief Executive Officer of Dyadic stated, "While Dyadic and its current and former officers and directors continue to firmly deny all allegations of wrongdoing, we also believe it is in the best interests of Dyadic and its stockholders to eliminate the continuing expense and disruption of litigation to our business and put this matter behind us. Settling this lawsuit removes a significant obstacle for Dyadic and allows us to continue the momentum we have gained over the past eighteen months, enabling us to better apply our resources in continuing to advance and leverage Dyadic’s products and technologies."

About Dyadic
Dyadic is a leading-edge early-stage biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. Please visit Dyadic’s website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

Contacts
Dyadic International, Inc.
Adam J. Morgan
Vice President General Counsel & Business Development
Phone: 561-743-8333
Email: amorgan@dyadic.com



Home Contact Site Map Important Legal Notice   Search © Dyadic 2008